Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-005220
Filing Date
2019-05-20
Accepted
2019-05-20 17:25:24
Documents
56
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rsls-20190331x10q.htm 10-Q 897833
2 EX-31.1 rsls-20190331ex311a79542.htm EX-31.1 13512
3 EX-31.2 rsls-20190331ex3122332f1.htm EX-31.2 14860
4 EX-32.1 rsls-20190331ex3211571fe.htm EX-32.1 11821
5 EX-32.2 rsls-20190331ex32238f766.htm EX-32.2 12080
  Complete submission text file 0001558370-19-005220.txt   3515894

Data Files

Seq Description Document Type Size
6 EX-101.INS rsls-20190331.xml EX-101.INS 586760
7 EX-101.SCH rsls-20190331.xsd EX-101.SCH 28996
8 EX-101.CAL rsls-20190331_cal.xml EX-101.CAL 52964
9 EX-101.DEF rsls-20190331_def.xml EX-101.DEF 108073
10 EX-101.LAB rsls-20190331_lab.xml EX-101.LAB 276266
11 EX-101.PRE rsls-20190331_pre.xml EX-101.PRE 222796
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 9494296680
ReShape Lifesciences Inc. (Filer) CIK: 0001371217 (see all company filings)

EIN.: 481293684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33818 | Film No.: 19839927
SIC: 3845 Electromedical & Electrotherapeutic Apparatus